Montefalcone Projects SRL
The score of Montefalcone Projects shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +220 % Total assets +146 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Montefalcone Projects's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 11 Dec 2025
- Year ended 30 Jun 2024filed on 13 Jan 2025
- Year ended 30 Jun 2023filed on 09 Jan 2024
- Year ended 30 Jun 2022filed on 21 Dec 2022
Montefalcone Projects's financial analysis
- Solvency78.7%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Montefalcone Projects
Montefalcone Projects's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0769.905.628
- VAT number
- BE0769905628
- Peppol
- Registered · 0208:0769905628 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Jun 2021
- Registered office
- 9681 Maarkedal
- Latest accounts
- 2025 · filed on 11 Dec 2025
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Montefalcone Projects (SRL) has been based in Maarkedal since 2021, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 46,000 € and equity of 163,406 €; its revenue is not published. Its solvency stands at 78.7%, above the median of its sector (56.0%).
Companies similar to Montefalcone Projects
Companies in the same business, of comparable size and area, outside its group.
- Abella Mar Manufacture of basic pharmaceutical products Kapellen · balance sheet 150,376 €
- BelCoPhar Manufacture of pharmaceutical preparations Kalmthout · balance sheet 224,468 €
- Mayaku Pharmaceutical Development Manufacture of basic pharmaceutical products Ghent · balance sheet 170,483 €
- Promacon Manufacture of basic pharmaceutical products Hove · balance sheet 408,759 €
- L - Pharma Manufacture of pharmaceutical preparations Turnhout · balance sheet 10 €
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
- huMAN Manufacture of basic pharmaceutical products Gerpinnes · balance sheet 186,227 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
Frequently asked questions about Montefalcone Projects
What is the revenue of Montefalcone Projects?
Montefalcone Projects files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Montefalcone Projects?
In Belgium, the VAT number is the company number prefixed with BE: BE0769905628 for Montefalcone Projects, if the company is VAT-registered. Its company number (CBE) is 0769.905.628.
Where is the registered office of Montefalcone Projects?
According to the CBE register, the registered office of Montefalcone Projects is in 9681 Maarkedal.
What is the equity of Montefalcone Projects?
At the close of the 2025 financial year, the equity of Montefalcone Projects amounts to 163,406 €, a solvency of 78.7% of total assets.
Who manages Montefalcone Projects?
The register lists 2 active mandates at Montefalcone Projects. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Montefalcone Projects
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →